gnews

Alkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabetes

Mutuum’s roadmap is aimed at expansion rather than a single launch moment. The project plans to deploy across multiple

Singapore, Singapore--(Newsfile Corp. - March 20, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company&

Evernorth CEO Asheesh Birla has addressed the growing divergence between XRP’s surging on-chain activity and its stagnant price.

A 2026 informational overview of how Purisaki Deep Cleansing Foot Pads are described in company materials - including the 2-in-

Mutuum is getting those early-utility-leader comparisons because the shape of the project already makes sense. It has a

Novo Nordisk is preparing for a surge of generic semaglutide drugs in India. The company's India head stated

The Polish lower house of parliament (Sejm) Dec. 9, 2025, accepted for consideration Bill No. 2363, to amend the act

STORY: Amazon is planning a smartphone comeback more than a decade after one of the company's most high-

Investor behavior has changed noticeably over the past few weeks, as risk aversion has risen sharply, according to Omar Aguilar,